Abiopharma

🔍 LIVEK WILLIAM PAUL (Executive)

Company: Red Violet, Inc. (RDVT)

Report Date: 2026-08-27

Detailed Transactions and Holdings:

• Acquired 2,000 shares of Common Stock at $71.49 per share (Direct)
  Date: 2026-08-27 | Code: P | equity_swap_involved: false | shares_owned_after: 22,733.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Includes 2,088 restricted stock units ("RSUs") originally granted on June 4, 2026, convertible into common stock of the issuer on a one-for-one basis, which vests on the earlier of June 4, 2027 or the 2027 annual meeting of stockholders, subject to accelerated vesting under certain conditions.
• F2: Includes 1,383 RSUs originally granted on January 5, 2024, convertible into common stock of the issuer on a one-for-one basis, which vests on December 1, 2026.
• F3: Includes 2,506 RSUs originally granted on November 4, 2024, convertible into common stock of the issuer on a one-for-one basis, which vests in two equal installments on each of November 1, 2026 and November 1, 2027, subject to accelerated vesting under certain circumstances.
• F4: Includes 1,484 RSUs originally granted on March 4, 2025, convertible into common stock of the issuer on a one-for-one basis, which vests in two equal installments on each of November 1, 2026 and November 1, 2027, subject to accelerated vesting under certain circumstances.
• F5: Includes 4,517 vested RSUs in which the reporting person has elected to defer delivery until the reporting person's separation of service from the issuer or death or disability.
• F6: Includes 3,755 RSUs originally granted on December 19, 2025, convertible into common stock of the issuer on a one-for-one basis, which vests in three equal installments on each of December 1, 2026, December 1, 2027, and December 1, 2028, subject to accelerated vesting under certain circumstances.